EYNSHAM MEDICAL GROUP
EYNSHAM MEDICAL CENTRE, CONDUIT LANE, EYNSHAM, WITNEYHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 18 | 28 | 64.3% | |
HF 4 | 2011 | 23 | 36 | 63.9% | |
HF 4 | 2012 | 29 | 35 | 82.9% | |
HF 4 | 2013 | 20 | 28 | 71.4% | |
HF004 | 2014 | 15 | 22 | 68.2% | |
HF004 | 2015 | 17 | 23 | 73.9% | |
HF004 | 2016 | 17 | 23 | 73.9% | |
HF004 | 2017 | 23 | 27 | 85.2% | |
HF004 | 2018 | 24 | 26 | 92.3% | |
HF004 | 2019 | 31 | 33 | 93.9% | |
HF004 | 2020 | 44 | 47 | 93.6% | |
HF006 | 2021 | 72 | 82 | 87.8% | |
HF006 | 2022 | 76 | 80 | 95.0% | |
HF006 | 2023 | 95 | 101 | 94.1% |